566 related articles for article (PubMed ID: 33951440)
1. mTOR signaling regulates gastric epithelial progenitor homeostasis and gastric tumorigenesis via MEK1-ERKs and BMP-Smad1 pathways.
Li K; Wu H; Wang A; Charron J; Mishina Y; Habib SL; Liu H; Li B
Cell Rep; 2021 May; 35(5):109069. PubMed ID: 33951440
[TBL] [Abstract][Full Text] [Related]
2. Invasive mouse gastric adenocarcinomas arising from Lgr5+ stem cells are dependent on crosstalk between the Hedgehog/GLI2 and mTOR pathways.
Syu LJ; Zhao X; Zhang Y; Grachtchouk M; Demitrack E; Ermilov A; Wilbert DM; Zheng X; Kaatz A; Greenson JK; Gumucio DL; Merchant JL; di Magliano MP; Samuelson LC; Dlugosz AA
Oncotarget; 2016 Mar; 7(9):10255-70. PubMed ID: 26859571
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of mTOR activation by diacylglycerol kinases.
Gorentla BK; Wan CK; Zhong XP
Blood; 2011 Apr; 117(15):4022-31. PubMed ID: 21310925
[TBL] [Abstract][Full Text] [Related]
4. Roles of Src family kinase, Ras, and mTOR signaling in intestinal epithelial homeostasis and tumorigenesis.
Matozaki T; Kotani T; Murata Y; Saito Y
Cancer Sci; 2021 Jan; 112(1):16-21. PubMed ID: 33073467
[TBL] [Abstract][Full Text] [Related]
5. Notch signaling regulates gastric antral LGR5 stem cell function.
Demitrack ES; Gifford GB; Keeley TM; Carulli AJ; VanDussen KL; Thomas D; Giordano TJ; Liu Z; Kopan R; Samuelson LC
EMBO J; 2015 Oct; 34(20):2522-36. PubMed ID: 26271103
[TBL] [Abstract][Full Text] [Related]
6. The TSC1-mTOR-PLK axis regulates the homeostatic switch from Schwann cell proliferation to myelination in a stage-specific manner.
Jiang M; Rao R; Wang J; Wang J; Xu L; Wu LM; Chan JR; Wang H; Lu QR
Glia; 2018 Sep; 66(9):1947-1959. PubMed ID: 29722913
[TBL] [Abstract][Full Text] [Related]
7. Epithelial BMP signaling is required for proper specification of epithelial cell lineages and gastric endocrine cells.
Maloum F; Allaire JM; Gagné-Sansfaçon J; Roy E; Belleville K; Sarret P; Morisset J; Carrier JC; Mishina Y; Kaestner KH; Perreault N
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1065-79. PubMed ID: 21415412
[TBL] [Abstract][Full Text] [Related]
8. Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.
Penna I; Molla A; Grazia G; Cleris L; Nicolini G; Perrone F; Picciani B; Del Vecchio M; de Braud F; Mortarini R; Anichini A
Oncotarget; 2016 Jan; 7(4):3947-65. PubMed ID: 26678033
[TBL] [Abstract][Full Text] [Related]
9. Regulation of skeletal muscle insulin-stimulated signaling through the MEK-REDD1-mTOR axis.
Dungan CM; Williamson DL
Biochem Biophys Res Commun; 2017 Jan; 482(4):1067-1072. PubMed ID: 27913296
[TBL] [Abstract][Full Text] [Related]
10. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways.
Zhang Q; Wang X; Cao S; Sun Y; He X; Jiang B; Yu Y; Duan J; Qiu F; Kang N
Biomed Pharmacother; 2020 Aug; 128():110245. PubMed ID: 32454290
[TBL] [Abstract][Full Text] [Related]
11. mTOR Activation Initiates Renal Cell Carcinoma Development by Coordinating ERK and p38MAPK.
Wu H; He D; Biswas S; Shafiquzzaman M; Zhou X; Charron J; Wang Y; Nayak BK; Habib SL; Liu H; Li B
Cancer Res; 2021 Jun; 81(12):3174-3186. PubMed ID: 33863779
[TBL] [Abstract][Full Text] [Related]
12. mTOR disruption causes intestinal epithelial cell defects and intestinal atrophy postinjury in mice.
Sampson LL; Davis AK; Grogg MW; Zheng Y
FASEB J; 2016 Mar; 30(3):1263-75. PubMed ID: 26631481
[TBL] [Abstract][Full Text] [Related]
13. Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K/Akt/mTOR signaling pathway.
Liu Y; Chen S; Xue R; Zhao J; Di M
Biochem Biophys Res Commun; 2016 Feb; 470(2):350-355. PubMed ID: 26780727
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model.
Mi R; Ma J; Zhang D; Li L; Zhang H
J Genet Genomics; 2009 Jun; 36(6):355-61. PubMed ID: 19539245
[TBL] [Abstract][Full Text] [Related]
15. Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.
Sahan-Firat S; Temiz-Resitoglu M; Guden DS; Kucukkavruk SP; Tunctan B; Sari AN; Kocak Z; Malik KU
Inflammation; 2018 Feb; 41(1):276-298. PubMed ID: 29110153
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-224 aggrevates tumor growth and progression by targeting mTOR in gastric cancer.
Zhang Y; Li CF; Ma LJ; Ding M; Zhang B
Int J Oncol; 2016 Sep; 49(3):1068-80. PubMed ID: 27315344
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways.
Yuan KT; Li BX; Yuan YJ; Tan M; Tan JF; Dai WG; Feng WD; Zuo JD
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806499. PubMed ID: 30355273
[TBL] [Abstract][Full Text] [Related]
18. Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Hibdon ES; Razumilava N; Keeley TM; Wong G; Solanki S; Shah YM; Samuelson LC
Neoplasia; 2019 Jul; 21(7):702-712. PubMed ID: 31129492
[TBL] [Abstract][Full Text] [Related]
19. mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer.
Cash H; Shah S; Moore E; Caruso A; Uppaluri R; Van Waes C; Allen C
Oncotarget; 2015 Nov; 6(34):36400-17. PubMed ID: 26506415
[TBL] [Abstract][Full Text] [Related]
20. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.
Yang H; Wang X; Zhang Y; Liu H; Liao J; Shao K; Chu Y; Liu G
J Cell Physiol; 2014 Jan; 229(1):17-26. PubMed ID: 23804073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
